陷入一块岩石和一个艰难的地方之间:基于结构的药物设计当前的挑战
1Medicinal Chemistry and Drug Design Technologies Department, Chiesi Farmaceutici S.p.A, Research Center, Largo Belloli 11/a, 43122 Parma, Italy.
Drug discovery today
|July 19, 2024
概括
基于结构的药物设计 (SBDD) 面临着持续的挑战,尽管有许多实验结构. 本综述强调了计算机辅助药物设计 (CADD) 的常见障碍,以Rho相关蛋白激酶 (ROCK) 为案例研究.
科学领域:
- 药用化学 医学化学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 基于结构的药物设计 (SBDD) 随着实验目标结构的可用性增加,已经取得了显著的进步.
- 尽管取得了进展,但计算机辅助药物设计 (CADD) 的实施仍然复杂,面临着持续的挑战.
研究的目的:
- 为了说明日常CADD工作流程中遇到的实际挑战.
- 管理有关CADD能力的预期,并告知非CADD科学家存在的困难.
主要方法:
- 利用Rho关联蛋白激酶 (ROCK) 的公共领域结构和数据.
- 采用了以特定药物标 (ROCK) 为重点的案例研究方法,以证明CADD的复杂性.
主要成果:
- 确定并详细介绍了CADD科学家面临的几个常见挑战.
- ROCK案例研究说明了应用CADD技术的实际困难.
结论:
- 即使有丰富的结构数据,CADD也不是一个简单的过程.
- 了解这些挑战对于现实的项目规划和药物发现的跨学科合作至关重要.
相关概念视频
Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
192
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
192


